Reports related to this article:
Project(s): View 1 related project in Energy Live
Catalent, a leading drug contract manufacturing organization (CMO), has a $114 million expansion underway at its Bloomington, Indiana, production plant. First reported by Industrial Info in January 2019, the project launched late last year. The expansion adds 79,000 square feet of biological fill and finish capacity. When completed next year, it will help the company's alliance with Johnson & Johnson in production of an eventual COVID-19 vaccine.
/iirenergy/industry-news/article.jsp
false
Want More IIR News?
Make us a Preferred Source on Google to see more of us when you search.
Add Us On GoogleAsk Us
Have a question for our staff?
Submit a question and one of our experts will be happy to assist you.
Explore Our EnergyLive Tools
EnergyLive Tools provide instant insight into new build, outages, maintenance, and capacity shifts across key energy sectors.
Learn MoreRelated Articles
-
Catalent Amps Up Contract Biological Manufacturing Capacity ...January 08, 2019
-
Wisconsin Home to $3.7 Billion in Projects Under Constructio...November 26, 2024
-
Novo Nordisk Spends $11 Billion to Make More Weight Loss Dru...February 15, 2024
-
EU Adds New COVID-19 Manufacturing CapacitySeptember 07, 2021
Explore Our Energy Industry Reports
Gain the competitive edge with IIR Energy’s suite of energy market reports, designed for traders, analysts, and asset managers who rely on verified, real-time data.
Learn MoreIndustry Intel
-
From Data to Decisions: How IIR Energy Helps Navigate Market VolatilityOn-Demand Podcast / Nov. 18, 2025
-
Navigating the Hydrogen Horizon: Trends in Blue and Green EnergyOn-Demand Podcast / Nov. 3, 2025
-
ESG Trends & Challenges in Latin AmericaOn-Demand Podcast / Nov. 3, 2025
-
2025 European Transportation & Biofuels Spending OutlookOn-Demand Podcast / Oct. 27, 2025
-
2025 Global Oil & Gas Project Spending OutlookOn-Demand Podcast / Oct. 24, 2025